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Summary
Background: People with substance use disorders present high psychopathological comorbidity. Research has dem-
onstrated that bereaved individuals with Complicated Grief (CG) symptomatology present unusually severe and pro-
longed symptoms, and that affects important domains. Aim: This study aimed to assess the association between clinical 
syndromes and CG symptoms among patients with Substance User Disorder (SUD). Methods: A convenience sample 
of 196 bereaved drug-dependent patients was studied. Sociodemographic characteristics, bereavement and drug-related 
variables as well as psychopathology were examined. CG symptomatology was measured by the Spanish version of the 
Inventory of Complicated Grief (ICG). Anxiety, Major Depressive Disorder and Posttraumatic Stress Disorder (PSTD) 
were assessed by utilizing the clinical syndrome section of the Spanish version of MCMI-III. A logistic regression analy-
sis was adjusted to identify which variables were associated with CG symptoms. Results: 78.1% were men, and mean 
age in the sample was 45.59 years (SD=10.14). 34.2% of participants reported symptomatology of CG. Individuals with 
CG symptoms showed 31.2% higher frequency of Anxiety, 12.5% higher Major Depression and 7.4% higher PTSD. The 
symptomatology of CG was associated with the presence of Major Depressive Disorder (OR= 1.029) as well as PTSD 
(OR=1.041). Conclusions: Depression and PTSD were associated with symptomatology of CG. This study suggests the 
importance of carrying out a rigorous and accurate differential diagnosis of CG symptomatology as well as clinical syn-
dromes among addicted people.
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1. Introduction
Although psychological responses to loss of a 
significant person are complex and vary in intensity 
and types of symptoms [2, 44], majority of patients 
can manage the loss with minimal disruptions in func-
tioning, while others experience initially acute symp-
toms that gradually subside [22]. However, a subset 
of bereaved individuals, usually 10-15% of the total, 
experience persistent and disabling symptoms [4, 23] 
called complicated grief (CG) [48]. This symptoma-
tology includes intense feelings of yearning, longing 
or emotional pain, separation distress, frequent preoc-
cupying thoughts and memories of the deceased per-
son, a feeling of disbelief or an inability to accept the 
loss, avoidance of and intense distress at reminders, 
difficulty in imagining a meaningful future without 
the deceased person, and substantial impairments to 
social and role obligations [3, 46]. 
In addition, several studies have further sup-
ported the fact that symptoms of CG are separable 
from other psychiatric diagnoses such as Major De-
pressive Disorder, Post-traumatic Stress Disorder 
(PTSD) and Anxiety [2, 5, 13, 18, 31, 37, 42]. These 
studies provide evidence that the different syndromes 
are not isomorphic and the core symptom clusters are 
empirically dissociable [12]. In this sense, the point 
to be made is that the response to the PTSD stressor 
must involve fear or horror, and is thus subjective [1] 
whereas a reaction to bereavement does not involve 
fear, although it may implicate feelings of helpless-
ness [35]. Despite the fact that the traumatic distress 
symptoms of CG appear to be similar to some of the 
symptoms of PTSD, the separation distress compo-
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nent is unique [18]. Some authors [38] differentiate 
CG symptoms from those of PTSD in clarifying how 
the person who presents the former tends to avoid 
memories that evoke the absence of the deceased, 
or seeing things that remind them of the deceased, 
or remembering the deceased in any way. In PTSD, 
however, the person tries to avoid the memories as-
sociated with the traumatic event. As it is related to 
depression, CG symptomatology is defined by long-
ing and guilt related to that specific death, and by 
preoccupation with thoughts and memories of the 
deceased. In contrast, Major Depressive Disorder is 
linked with general sadness, guilt, shame or low self-
esteem [43]. Although CG symptoms and depression 
are frequently comorbid, they can occur indepen-
dently [10]. From the same perspective, in studies on 
bereaved individuals, yearning loads highly on the 
grief factor, but not on depression or anxiety factors, 
whereas sadness loads only on a depression factor, 
while feeling nervous and worried loads only on an 
anxiety factor [16, 31, 34]. 
Several studies suggest that CG symptomatol-
ogy is common in treatment samples in which psychi-
atric outpatients have being sought. Studies in clini-
cal settings in different countries revealed that about 
a third of psychiatric outpatients may have symptoms 
of CG: that was true of 33% of psychiatric outpatients 
in Vancouver, [32] and 34% of psychiatric outpatients 
in Pakistan [36]. A German study of 73 inpatients 
with unipolar depression found an 18% rate of CG 
[15]. Those who met this criterion had greater sever-
ity of other co-occurring psychiatric disorders [42].
Taking into account the focus sample of the 
present study, it is important to consider the high co-
morbidity existing among people with SUD [6, 9, 11, 
29, 30, 40, 50]. Individuals with co-occurring Ma-
jor Depressive Disorder, anxiety or PTSD and SUD 
report more severe symptomatology, greater health 
problems, greater functional impairments, and fare 
less well in treatment, which contributes to a height-
ened vulnerability to relapse after discharge [8, 39]. 
An American study based on 401 drug-dependent 
individuals shows that several baseline psychiatric 
disorders predicted worse outcomes at follow up. 
Major Depressive Disorder predicted the use of a 
larger number of substances and having more drug 
dependence diagnoses and symptoms [8]. 21% of an-
other American sample (participants in 10 geographi-
cally diverse outpatient drug treatment programmes) 
screened positive for depression and were significant-
ly more likely to screen positive for anxiety (66.9%), 
and almost half of them for PTSD (42.9%) [41]. A 
Spanish study found that 36.5% of the 115 patients 
with cocaine dependence in treatment presented psy-
chiatric disorder criteria [21].
There is a lack of evidence regarding clinical 
syndromes and CG symptomatology among SUD 
populations. For this reason, the present study aims to 
assess the association between the presence of clini-
cal syndromes (Anxiety, Major Depressive Disorder, 
PTSD) and CG symptoms among bereaved people 
with SUD.
2. Methods
2.1. Design of the study
We used an observational and cross-sectional 
design.
2.2. Sample
Recruitment of patients was based on a con-
venience sampling procedure. The participants in this 
study were 196 adult patients (78.1% male) receiving 
treatment at the Public Addiction Treatment Centre in 
Girona (Catalonia, Spain). The inclusion criteria were 
1) they had a diagnosis of alcohol, cocaine or heroin 
dependence carried out by clinical specialists in the 
centre according to DSM-IV-TR criteria, 2) they had 
suffered a loss of a significant person (family, best 
friend or partner) at some time in their life, but at least 
a year previously to the interview, and any bereave-
ment within the year previous to the interview would 
exclude them from this study, and 3) abstinence dur-
ing the last month to avoid the toxic effect of drugs. 
2.3. Instruments
We used an ad hoc questionnaire to register so-
ciodemographic characteristics (age, gender, marital 
status, education and work status), bereavement-re-
lated variables (the most significant/closest loss expe-
rience, time since death and circumstances of death), 
as well as drug use-related variables (main drug de-
pendence). 
Complicated grief was measured using the 
Spanish version of the Inventory of Complicated 
Grief (ICG) [17]. It consists of 19 items. Responses 
are provided on a 5-point Likert scale to indicate an 
increase in severity (0-never, 1-seldom, 2-sometimes, 
3-often and 4-always) (maximum score: 76). The cut-
off point was 25, it was based on the English version 
of the ICG [29]. We categorized a respondent as hav-
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ing symptoms of CG if the total score was higher than 
25. The internal consistency of the Spanish version 
was high (Cronbach’s alpha = 0.88; test-retest reli-
ability = 0.81).
Anxiety, Major Depressive Disorder and PTSD 
were assessed using the Spanish version of Millon 
Clinical Multiaxial Inventory-III (MCMI-III) [28]; 
Spanish translation by Cardenal and Sánchez-López 
[7]. We used the most conservative criteria with scores 
equal to or greater than 85 to define the presence of 
the clinical syndromes. The MCMI-III is a 175 item 
self-report questionnaire with dichotomous answers 
(true/false). It measures 11 clinical personality pat-
terns, 3 traits of severe personality pathology, 7 syn-
dromes of moderate severity, 3 severe syndromes and 
a validity scale with 3 modifying indices. The per-
sonality disorders scales cover the major diagnostic 
criteria of DSM-IV. The internal consistency ranges 
between 0.66 and 0.80, and the test-retest reliability 
for dimensional ratings has a range of 0.85 to 0.93. 
The test-retest reliability for the categorical diagnosis 
is Kappa <0.45. To correlate with the MCMI scores, 
SCL-90-R (Symptomatological Check List in its re-
vised form) and the Inventory Minnesota Multiphasic 
Personality (MMPI) scores >0.50 were used. MCMI 
shows a sensitivity range of 0.44-0.92 (mean=0.60), 
and its predictive power has a range of 0.30 to 0.81 
(mean=0.69). 
2.4. Procedure
Each participant who met the three inclusion 
criteria was informed by his/her therapist about their 
possible participation in the study. If patients agreed 
to collaborate, the psychologist (who is the first au-
thor) called each patient to arrange an appropriate 
time for an interview in the centre. All participants 
were informed about the study procedure as well as 
terms of confidentiality. The average time for each 
interview was one hour and a half in total. Informed 
consent was obtained from all participants, and the 
protocol was approved by the Institutional Ethics and 
Research Review Board of the Institut Assistència 
Sanitària (IAS). 
2.5. Data analysis
In order to compare normal grievers with com-
plicated grievers, we used chi-square tests, to iden-
tify relationships between the categorical variables 
(applying the Yates correction when necessary) and 
the Student’s t-tests, to determine the relationship be-
tween the quantitative and the qualitative variables. 
To assess the association between CG symptoms 
and clinical syndromes we performed a logistic re-
gression. The results are expressed as absolute num-
bers, percentages, odds ratios, as well as showing the 
means and standard deviations. To assess the relation 
between different variables and CG, we adjusted a 
logistic regression model using the presence or ab-
sence of symptoms of CG (dichotomous variable) as 
dependent variables and the following factors as inde-
pendent variables: gender (1=male; 2=female), edu-
cation (1=primary; 2=secondary and beyond), marital 
status (married as a reference category), work status 
(working as a reference category), relationship with 
the deceased (father as a category), circumstances of 
death (1=natural; 2=traumatic), and the three clini-
cal syndromes (Anxiety Disorder; PTSD and Ma-
jor Depressive Disorder) as dimensional variables. 
A statistical significance of 0.05 was set for testing 
the hypotheses. All analyses were carried out using 
the Statistical Package for the Social Sciences (SPSS 
21.0) for Windows.
3. Results
3.1. Sociodemographic and drug-related 
characteristics 
The mean (SD) age of the clinical sample was 
45.59±10.14 years and 78% (n=153) were men.
As shown in Table 1, education background was 
found to be statistically significant. The majority of 
normal grievers report a history of secondary educa-
tion. With respect to working status, 67.3% of com-
plicated grievers reported no working status.
Considering now the addiction variables, more 
than a half of the individuals reported alcohol de-
pendence as the first main diagnosis (68.9%), 18.4% 
heroin dependence and 12.8% cocaine dependence. 
74.5% of the substance use participants were taking a 
prescribed psychopharmacological therapy. 
3.2. Bereavement variables
Among the complicated bereaved substance us-
ers, the sibling was the most frequently-experienced 
significant deceased person, followed by 22.4% for 
the father. In contrast, the father was the relative most 
frequently experienced (40.3%) among normal griev-
ers. More than a half of participants with CG symp-
tomatology (50.9%) indicated “traumatic” as the 
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most frequent circumstance of death (Table 2).
3.3. Presence of clinical syndromes
The three disorders (Anxiety, Major Depres-
sive Disorder and PTSD) were statistically significant 
as comorbidities in those patients who reported CG 
symptoms. Anxiety disorder was the most frequent 
disorder. More than a half (53.7%) of addicted indi-
viduals with CG symptoms also presented Anxiety 
Disorder, 17.9% presented symptoms of Major De-
pressive Disorder and 9% PTSD (Table 3).
3.4. Variables associated with CG symptomatology
Table 4 shows the results of a logistic regression 
in which scores of CGs were the dependent variables, 
while sociodemographic and bereavement variables 
as well as psychopathological disorders were con-
sidered independent variables. It was found that be-
ing a woman, together with the condition of being 
separated or divorced, showed an association with 
CG symptoms. Participants who lost their sibling re-
ported a higher risk of presenting CG symptoms. As 
to comorbidity, presenting PTSD in combination with 
a Major Depressive Disorder was strongly associated 
with the symptomatology of CG.
4. Discussion
The current study aimed to increase knowledge 
about the relationships between CG and clinical syn-
Table 1. Sociodemographic variables
    Normal grievers (n=129) Complicated grievers (n=67) p
Gender
Man 103 (79.8) 50 (74.6) 0.40 a
Women 26 (20.2) 17 (25.4)
Age, M (SD) 45.43 (10.36) 45.85 (9.7) 0.14 b
Marital status
Single 27 (20.9) 17 (25.4) 0.15 a
Married/partner 49 (38) 24 (35.8)
Separated/divorced 46 (35.7) 17 (25.4)
Widowed 7 (5.4) 9 (13.4)
Studies
Primary education 29 (23.2) 30 (45.5) 0.002 a
Secondary and beyond 96 (76.8) 36 (54.5)
Work status
Working 50 (38.8) 22 (32.8) 0.02 a
Others* 79 (61.4) 45 (67.3)  
* Retired, unemployed, inactive, disability aid; a chi-square test; b t-test test.
Table 2. Bereavement variables (n (%))
    Normal grievers (n=129)
Complicated grievers
(n=67) p
Relationship to deceased Father 52 (40.3) 15 (22.4) <0.001a
Mother 30 (23.3) 7 (10.4)
Sibling 12 (9.3) 24 (35.8)
Grandparent 9 (7) 2 (3)
Friend 10 (7.8) 4 (6)
Spouse 9 (7) 10 (14.9)
Others 7 (5.4) 5 (7.5)
Time since death, M (SD)  13.33 (11.48) 9.36 (9.78)  0.02b
Circumstances of death Natural 102 (71.8) 26 (49.1)  0.003a
No natural* 40 (28.2) 27 (50.9)
CG symptoms M, (SD) 11.37 (7.02) 41.67 (10.85) <0.001b
a chi-square test; b t-test test. * No natural: Accident, Suicide, Homicide and Overdose
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dromes among substance users. Participants with 
SUD reported high scores in ICG, showing 34.2% of 
CG symptoms, as presented in another publication 
arising from the same study [26]. We found that par-
ticipants with CG symptoms also reported a higher 
frequency of clinical syndromes. Taking into account 
that we used the most conservative criteria by includ-
ing only scores equal to or greater than 85, more than 
half of the individuals in the sample (53.7%) present-
ed Anxiety Disorder, almost two out of ten (17.9%) 
reported Major Depressive Disorder and 9% PTSD. 
These results were along the same lines as those of 
other studies [32, 42], despite the fact that those stud-
ies were focused on psychiatric samples, whereas the 
current study was based specifically on people with 
SUD.
The final objective of this research was to iden-
tify which variables can be associated with symp-
toms of CG among SUD patients. Logistic regression 
analysis allowed us to examine the complexity of the 
CG construct. In connection with sociodemographic 
and bereavement variables, we concluded that CG 
symptomatology was associated with gender (being 
a woman), with being separated or divorced, and hav-
ing lost a sibling. General population studies simi-
larly raised the issue of gender, because of the fact 
that being a woman was found to carry a greater risk 
of developing CG symptoms than for men, as found 
Table 3. Clinical syndromes found in the sample (n (%))
    Complicated grievers (n=129)
Normal grievers 
(n=67) P
Anxiety M (SD) 82.45 (18.41) 56.04 (32.72) 0.000 a
Yes 36 (53.7) 29 (22.5) 0.000 b
No 31 (46.3) 100 (77.5)
Depression M (SD) 64.93 (22.59) 35.84 (29.31) 0.000 a
Yes 12 (17.9) 7 (5.4) 0.005 b
No 55 (82.1) 122 (94.6)
PTSD M (SD) 64.99 (17.06) 41.21 (25.58) 0.000 a
Yes 6 (9) 2 (1.6) 0.013 b
  No 61 (91) 127 (98.4)  
a t-test test; b chi-square test
Table 4. Logistic regression of associated variables in CG’s symptomatology
  B E.T. Wald df Sig. Exp(B)
Age .007 .023 .095 1 .758 1.007
Woman 1.251 .572 4.783 1 .029 3.494
No working status -.288 .468 .377 1 .539 .750
Primary studies -.744 .448 2.763 1 .096 .475
Marital status 8.405 3 .038
Married or in a couple -.918 .595 2.382 1 .123 .399
Separated or divorced -1.753 .623 7.920 1 .005 .173
Widow -.245 1.190 .042 1 .837 .783
Relationship with the deceased 10.265 6 .114
Mother .281 .658 .182 1 .670 1.324
Sibling 1.680 .641 6.861 1 .009 5.365
Grandparent -.417 .960 .189 1 .664 .659
Friend -.129 .868 .022 1 .882 .879
Spouse 1.096 1.058 1.073 1 .300 2.992
Others 1.047 .871 1.446 1 .229 2.850
Traumatic circumstances of death 1.069 .561 3.633 1 .057 2.912
Anxiety .005 .015 .106 1 .745 1.005
PTSD .040 .019 4.337 1 .037 1.041
Depression .029 .011 7.556 1 .006 1.029
Constant -4.652 1.456 10.208 1 .001 .010
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independently in our study [19, 20, 45].
With respect to the clinical syndromes, symp-
toms of CG were associated with Major Depressive 
disorder and PTSD disorder. These two clinical syn-
dromes reported a high association with the con-
struct of CG symptoms. These results were along the 
same lines as those in other studies [6, 27, 49]. De-
spite overlap with the criteria for CG symptoms and 
Anxiety, Depression and PTSD reactions following 
bereavement, the phenomenological distinctiveness 
of CG symptoms (such as yearning, searching, disbe-
lief), from those of bereaved-related anxiety, depres-
sion and PTSD was shown in several studies on the 
general population [12, 31]. To sum up, CG symp-
toms showed incremental validity in predicting physi-
cal problems after checking for the effects of Major 
Depressive disorder, anxiety and PTSD following the 
bereavement in question [12].
Limitations
This study had a number of limitations. We re-
lied exclusively on self-report measures. Moreover, 
the clinical syndromes were assessed with the psy-
chometric test focus on personality disorders. The 
present study had a cross-sectional design instead of 
a longitudinal design; hence causal inferences cannot 
be made. 
5. Clinical implications
The comorbidities portend challenges that lie 
ahead for patients and clinicians alike [40]. It is high-
ly valuable to have clear correlations between specific 
comorbid psychiatric disorders and SUD in order to 
appropriately treat patients [8]. At a therapeutic level, 
it would be appropriate to take into account whether 
the patients have experienced the loss of a significant 
person in their life and how the factors could affect 
them. Moreover, most individuals with undiagnosed 
CG would be relieved to know that their symptoms 
are indicative of an identifiable syndrome and might 
be interested in receiving treatment for their grief 
[14]. Finding clear correlations between specific co-
morbid psychiatric disorders for those in substance 
use treatment would have important implications for 
predicting treatment outcomes [8, 51]. 
6. Conclusions
This study highlights psychiatric comorbidity 
among substance users. Our data demonstrate that 
comorbid disorders may be a risk factor for CG 
symptomatology. Specifically, our results indicate 
that Major Depressive disorder and PTSD are clinical 
syndromes related to CG symptomatology.
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